TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›ALUR›Financials
Annual statements · SEC XBRL · FY2022 – FY2025

ALLURION TECHNOLOGIES, INC. (ALUR) financials

Income statement

ALLURION TECHNOLOGIES, INC. (ALUR) income statement, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Revenue$64.2M$53.5M$32.1M$15.2M
Revenue growth—-16.7%-39.9%-52.6%
Gross profit$50.7M$41.5M$21.5M$9.57M
Gross margin79.0%77.6%67.0%62.8%
Operating income-$32.0M-$79.1M-$50.2M-$30.2M
Operating margin-49.9%-147.9%-156.3%-198.0%
Net income-$37.7M-$80.6M-$7.20M-$28.8M
Net margin-58.8%-150.8%-22.4%-188.8%
EPS (diluted)-$1.51-$57.83-$3.20-$3.81

Cash flow

ALLURION TECHNOLOGIES, INC. (ALUR) cash flow, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Operating cash flow-$47.0M-$64.0M-$42.3M-$28.9M
Capital expenditures$1.55M$1.61M$611K—
Free cash flow-$48.5M-$65.6M-$42.9M—

Balance sheet

ALLURION TECHNOLOGIES, INC. (ALUR) balance sheet, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Cash & equivalents$7.68M$38.0M$15.4M$5.41M
Total assets$51.4M$71.7M$32.8M$15.8M
Total liabilities$83.7M$142M$111M$93.0M
Long-term debt$3.10M—$35.7M—
Shareholders' equity-$32.3M-$71.3M-$78.0M-$77.2M
Retained earnings-$132M-$213M-$222M-$251M
Shares (wtd avg diluted)26.9M1.42M2.25M7.54M

Every figure is extracted from ALLURION TECHNOLOGIES, INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is ALLURION TECHNOLOGIES, INC.'s annual revenue?
ALLURION TECHNOLOGIES, INC. (ALUR) reported $15.2M of revenue for fiscal year 2025 — down 52.6% from $32.1M in FY2024, per its annual report filed with the SEC.
Is ALLURION TECHNOLOGIES, INC. profitable?
Not in FY2025 — ALUR reported a net loss of $28.8M, per SEC filings.
Does ALUR pay a dividend?
ALLURION TECHNOLOGIES, INC. reported no cash dividends paid in FY2025, per its SEC cash-flow statement.
Full ALUR analysis — verdict, score & filings →Is ALUR a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.